Does it Pay to Use Pathways?

Segment 11 - Integrating Pathways into the Value-Based Framework
June 30, 2014 – 
Panelists discussed the successes and failures associated with pathway implementation.
Segment 10 - Evidence-Based Medicine in the "Real-World" Healthcare Setting
June 30, 2014 – 
The panelists continued to discuss evidence-based medicine, as well as the incentives there might be to examine emerging and existing therapies or drugs.
Segment 9 - The Use of Expensive or New Immunotherapies in Clinical Pathways
June 30, 2014 – 
In regard to updating pathways and guidelines, Dr Sonnad asked about the opportunity for newer, expensive immunotherapies to be included in a pre-determined pathway.
Segment 8 - Financial Incentives and Penalties
June 30, 2014 – 
Panelists analyzed the concept of penalizing providers who deviate from pathway programs.
Segment 7 - The Complexities of Pathway Development
June 30, 2014 – 
Dr Sonnad inquired how replacing brand drugs with generic equivalents can affect pathway adherence. She also asked panelist to discuss the differences between early-stage and late-stage disease regimens, as well as the degree of flexibility there is in regimen design.
Segment 6 - The Importance of Feedback
June 30, 2014 – 
The panelists further explore feedback and its role in pathway adherence.
Segment 5 - The Use of Tools and Electronic Health Records in Pathway Adherence
June 30, 2014 – 
In this segment, panelists discussed the various tools that are used to measure pathway adherence.
Segment 4 - Payer Panel Pathway Recommendations
June 30, 2014 – 
Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Segment 3 - Provider Buy-in and Clinical Pathway Development
June 30, 2014 – 
Dr Yu said that it is crucial for providers' voices to be heard in pathway development.
Segment 2 - Development of Pathway Guidelines
June 30, 2014 – 
The panelists discussed and shared examples of how payers and providers are collaborating to develop pathway guidelines.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!